Kidder Stephen W Novartis Ag Transaction History

Kidder Stephen W

$333 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$92.57 - $107.37 $662,338 - $768,232	-7,155 Reduced 57.66%	5,254 $559,000
Q1 2024 May 13, 2024	SELL	$95.27 - $108.47 $747,583 - $851,164	-7,847 Reduced 38.74%	12,409 $1.2 Million
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $702,082 - $772,617	-7,609 Reduced 27.31%	20,256 $2.05 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $20,840 - $23,128	-220 Reduced 0.78%	27,865 $2.84 Million
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $8,326 - $9,441	90 Added 0.32%	28,085 $2.83 Million
Q1 2023 May 10, 2023	SELL	$80.03 - $92.81 $88,033 - $102,091	-1,100 Reduced 3.78%	27,995 $2.58 Million
Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $755 - $925	-10 Reduced 0.03%	29,095 $2.64 Million
Q3 2022 Nov 08, 2022	SELL	$74.61 - $87.26 $162,276 - $189,790	-2,175 Reduced 6.95%	29,105 $2.21 Million
Q2 2022 Jul 19, 2022	SELL	$80.52 - $93.75 $717,594 - $835,500	-8,912 Reduced 22.17%	31,280 $2.64 Million
Q1 2022 May 17, 2022	SELL	$80.11 - $90.62 $204,520 - $231,352	-2,553 Reduced 5.97%	40,192 $3.53 Million
Q4 2021 Feb 08, 2022	SELL	$79.7 - $88.13 $1.11 Million - $1.23 Million	-13,923 Reduced 24.57%	42,745 $3.74 Million
Q3 2021 Nov 10, 2021	SELL	$81.78 - $95.14 $534,595 - $621,930	-6,537 Reduced 10.34%	56,668 $4.63 Million
Q2 2021 Aug 09, 2021	SELL	$85.24 - $94.15 $561,390 - $620,071	-6,586 Reduced 9.44%	63,205 $5.77 Million
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $382,430 - $450,992	-4,580 Reduced 6.16%	69,791 $5.97 Million
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $121,008 - $146,366	-1,550 Reduced 2.04%	74,371 $7.02 Million
Q3 2020 Oct 28, 2020	SELL	$82.14 - $91.0 $29,570 - $32,760	-360 Reduced 0.47%	75,921 $6.6 Million
Q2 2020 Jul 28, 2020	BUY	$80.93 - $91.1 $7,688 - $8,654	95 Added 0.12%	76,281 $6.66 Million
Q1 2020 May 07, 2020	SELL	$70.67 - $99.01 $64,097 - $89,802	-907 Reduced 1.18%	76,186 $6.28 Million
Q4 2019 Jan 15, 2020	SELL	$84.35 - $95.37 $133,104 - $150,493	-1,578 Reduced 2.01%	77,093 $7.3 Million
Q3 2019 Nov 07, 2019	BUY	$85.54 - $94.26 $149,267 - $164,483	1,745 Added 2.27%	78,671 $6.84 Million
Q2 2019 Jul 24, 2019	SELL	$75.4 - $92.8 $86,860 - $106,905	-1,152 Reduced 1.48%	76,926 $7.02 Million
Q1 2019 May 01, 2019	SELL	$75.32 - $86.15 $498,618 - $570,313	-6,620 Reduced 7.82%	78,078 $7.51 Million
Q4 2018 Jan 24, 2019	SELL	$73.66 - $82.02 $129,346 - $144,027	-1,756 Reduced 2.03%	84,698 $7.27 Million
Q3 2018 Oct 15, 2018	SELL	$66.94 - $77.43 $100,410 - $116,145	-1,500 Reduced 1.71%	86,454 $7.45 Million
Q2 2018 Jul 30, 2018	BUY	$64.91 - $73.36 $70,102 - $79,228	1,080 Added 1.24%	87,954 $6.64 Million
Q1 2018 Apr 24, 2018	SELL	$70.39 - $84.15 $226,866 - $271,215	-3,223 Reduced 3.58%	86,874 $7.02 Million
Q4 2017 Feb 02, 2018	BUY	$72.33 - $77.64 $57,068 - $61,257	789 Added 0.88%	90,097 $7.57 Million
Q3 2017 Oct 26, 2017	BUY	$74.14 - $77.27 $6.62 Million - $6.9 Million	89,308	89,308 $7.67 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kidder Stephen W, based on Form 13F filings with the SEC.

News

Stay updated on Kidder Stephen W with notifications on news.

Account